达安基因(002030) - 2017年10月30日调研活动附件

Group 1: Company Overview - The company is represented by Secretary Zhang Bin and Assistant Vice President Thomas Tey Zhe An from Khazanah Nasional [2] Group 2: Key Financial Highlights - The report highlights significant financial metrics, including revenue growth and market performance [2]